Valeria Friuli
Overview
Explore the profile of Valeria Friuli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bini M, Bruni G, Sturini M, Rossetti B, Alaimo G, Auricchio F, et al.
Materials (Basel)
. 2025 Mar;
18(5).
PMID: 40077290
The increase in life expectancy has led to a rise of musculoskeletal disorders. Calcium phosphate cements (CPCs), thanks to some amazing features such as the ability to harden in vivo,...
2.
Buscarini A, Zaworotko M, Matos C, Grepioni F, Contini L, Capsoni D, et al.
Molecules
. 2024 Dec;
29(23).
PMID: 39683769
Pimozide is a first-generation antipsychotic used in the treatment of schizophrenia, Gilles de la Tourette syndrome, and other chronic psychoses. Its in vivo efficacy is limited by poor solubility and...
3.
Friuli V, Loi C, Bruni G, Maggi L, Bini M
Pharmaceutics
. 2024 Nov;
16(11).
PMID: 39598573
Background/objectives: Interest in drug delivery systems (DDS) based on inorganic substrates has increased in parallel with the increase in the number of poorly water-soluble drugs. Hydroxyapatite is one of the...
4.
Maggi L, Friuli V, Cerea B, Bruni G, Berbenni V, Bini M
Molecules
. 2024 Jun;
29(11).
PMID: 38893294
Organic-inorganic hybrids represent a good solution to improve the solubility and dissolution rates of poorly soluble drugs whose number has been increasing in the last few years. One of the...
5.
Friuli V, Urru C, Ferrara C, Conti D, Bruni G, Maggi L, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543233
The study focuses on the synthesis and characterization of Meloxicam-halloysite nanotube (HNT) composites as a viable approach to enhance the solubility and dissolution rate of meloxicam, a poorly water-soluble drug...
6.
Friuli V, Maggi L, Bruni G, Caso F, Bini M
Nanomaterials (Basel)
. 2024 Jan;
14(1).
PMID: 38202568
Poorly water-soluble drugs represent a challenge for the pharmaceutical industry because it is necessary to find properly tuned and efficient systems for their release. In this framework, organic-inorganic hybrid systems...
7.
Pisani S, Mauri V, Negrello E, Friuli V, Genta I, Dorati R, et al.
Pharmaceutics
. 2023 Oct;
15(10).
PMID: 37896239
Background: To make the regenerative process more effective and efficient, tissue engineering (TE) strategies have been implemented. Three-dimensional scaffolds (electrospun or 3D-printed), due to their suitable designed architecture, offer the...
8.
Maggi L, Friuli V, Bruni G, Rinaldi A, Bini M
Molecules
. 2023 May;
28(10).
PMID: 37241774
The search for effective systems to facilitate the release of poorly bioavailable drugs is a forefront topic for the pharmaceutical market. Materials constituted by inorganic matrices and drugs represent one...
9.
Maggi L, Urru C, Friuli V, Ferrara C, Conti D, Bruni G, et al.
Molecules
. 2023 Apr;
28(8).
PMID: 37110635
Carvedilol is a poorly water-soluble drug employed to treat chronic heart failure. In this study, we synthesize new carvedilol-etched halloysite nanotubes (HNTs) composites to enhance solubility and dissolution rate. The...
10.
Friuli V, Pisani S, Conti B, Bruni G, Maggi L
Polymers (Basel)
. 2022 May;
14(10).
PMID: 35632009
A challenge in the pharmaceutical sector is the development of controlled release dosage forms for oral administration of poorly soluble drugs, in particular, drugs characterized by pH-dependent solubility through the...